Diferencia entre revisiones de «H1N1 (swine) flu»
Sin resumen de edición |
|||
| Línea 26: | Línea 26: | ||
If the contact occurred with a patient after 7 days of symtpom onset, then chemoprophylaxis is not necessary. This is the presumed post-infectious period. | If the contact occurred with a patient after 7 days of symtpom onset, then chemoprophylaxis is not necessary. This is the presumed post-infectious period. | ||
==See Also== | |||
*[[Influenza]] | |||
[[Category:ID]] | [[Category:ID]] | ||
Revisión del 06:45 3 oct 2014
High-risk groups
- Pregnant- incr rates of SAB, preterm labor
- Chronic lung disease
- Immunosuppressed
- Cardiac
- DM
Screening
Individuals with an acute febrile respiratory illness (a measured temperature of 100ºF or higher and recent onset of at least one of the following: rhinorrhea, nasal congestion, sore throat, or cough) or sepsis-like syndrome- HIGH PRIORITY for hospitalized patients and those at high-risk for severe disease.
Diagnosis
- Rapid Flu nasal swab 60-80% sensitive in detecting influenza A
- If patient is negative, severely ill and will be hospitalized, send viral culture
- PCR is the recommended confirmatory test
Treatment
- All hospitalized patients with confirmed, probable or suspected novel influenza (H1N1)
- Patients who are at higher risk for seasonal influenza complications
Most effective when started within 48 hours of illness onset.
Adult: 75-mg capsule twice per day for 5 days
Post-exposure chemoprophylaxis
- Tamiflu 75mg po daily x 10 days (10 days after the last known exposure to novel (H1N1) influenza.)
If the contact occurred with a patient after 7 days of symtpom onset, then chemoprophylaxis is not necessary. This is the presumed post-infectious period.